Drug Profile
Research programme: sulfonyl hydrazine prodrugs - Vion
Alternative Names: KS 119; KS 119W; R-KS 119W; S-KS 119W; VNP 40541Latest Information Update: 08 Jan 2010
Price :
$50
*
At a glance
- Originator Yale University
- Developer Vion Pharmaceuticals
- Class Hydrazines
- Mechanism of Action Alkylating agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Suspended Cancer
Most Recent Events
- 17 Dec 2009 VPN 40541 is still available for licensing (http://www.vionpharm.com)
- 17 Dec 2009 Suspended - Preclinical for Cancer in USA (unspecified route)
- 25 Jun 2008 VPN 40541 is available for licensing (http://www.vionpharm.com)